Glucocorticoid Replacement and Mortality in Patients with Nonfunctioning Pituitary Adenoma
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Context: Current treatment guidelines generally suggest using lower and weight-adjusted glucocorticoid replacement doses in patients with insufficiency of the hypothalamic-pituitary-adrenal (HPA) axis. Although data in patients with acromegaly revealed a positive association between glucocorticoid dose and mortality, no comparable results exist in patients with nonfunctioning pituitary adenomas (NFPA). Objective: Our objective was to assess whether higher glucocorticoid replacement doses are associated with increased mortality in patients with NFPA and HPA axis insufficiency. Design, Participants, and Intervention: We included 105 patients receiving glucocorticoid replacement after pituitary surgery due to NFPA and concomitant HPA axis insufficiency. Patients were grouped according weight-adapted and absolute hydrocortisone (HC) replacement doses. Mortality was assessed using Kaplan-Meier methodology as well as multivariable Cox regression models. Setting: This was a retrospective analysis conducted at a tertiary referral center. Main Outcome: We evaluated overall mortality based on HC replacement doses. Results: Average age at inclusion was 58.9 ± 14.8 yr, and mean follow-up was 12.7 ± 9.4 yr. The groups did not differ according to age, follow-up time, pattern of hypopituitarism, and comorbidities. Kaplan-Meier survival probabilities differed significantly when comparing individuals with differing weight-adjusted HC dose (P = 0.001) as well as absolute HC dose (5–19, 20–29, and ≥30 mg, P = 0.009). Hazard ratios for mortality increased from 1 (0.05–0.24 mg/kg) to 2.62 (0.25–0.34 mg/kg) to 4.56 (≥0.35 mg/kg, P for trend = 0.006) and from 1 (5–19 mg) to 2.03 (20–29 mg) to 4 (≥30 mg, P for trend = 0.029), respectively. Conclusion: Higher glucocorticoid replacement doses are associated with increased overall mortality in patients with NFPA and insufficiency of HPA axis. This further substantiates the importance of a balanced and adjusted glucocorticoid replacement therapy in these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
The citation lists are queued
They are fetched later and appear here then.
References 15 · Cited by 90
Research works printed but not linked: 1
- Schimmer, 2006, Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormone, 1587
Metadata
- Authors
- Zueger, T., Kirchner, P., Herren, C., Fischli, S., Zwahlen, M., Christ, E., & Stettler, C.
- Affiliations
- Division of Endocrinology, Diabetes, and Clinical Nutrition (T.Z., P.K., C.H., E.C., C.S.), CH-3010 Bern, Switzerland
- Luzerner Kantonsspital (CH)
- University of Bern (CH)
- Corresponding author
- Stettler, Christoph
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-10-01
- Volume
- 97
- Issue
- 10
- Pages
- E1938-E1942
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2023143415
- Cited by
- 90
- References
- 15
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 7 · 2023: 5 · 2022: 4 · 2021: 7 · 2020: 7 · 2019: 7 · 2018: 5 · 2017: 5 · 2016: 13 · 2015: 10 · 2014: 8 · 2013: 4
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion)
- Funders
- University of Bern
- Inselspital, Universitätsspital Bern
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- non-functioning pituitary adenoma, glucocorticoid replacement therapy, cortisol, mortality, weight-based dosing, dose-response relationship, hypopituitarism, pituitary surgery
- MeSH terms
- Adenoma, Adult, Aged, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Glucocorticoids, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Middle Aged, Pituitary Neoplasms, Pituitary-Adrenal System, Retrospective Studies, Comorbidity, Growth Hormone-Secreting Pituitary Adenoma, Kaplan-Meier Estimate, Tertiary Care Centers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucocorticoid Replacement and Mortality in Patients with Nonfunctioning Pituitary Adenoma. https://app.cochat.ai/papers/10.1210/jc.2012-2432
- The paper
- Zueger, T., Kirchner, P., Herren, C., Fischli, S., Zwahlen, M., Christ, E., & Stettler, C. (2012). Glucocorticoid Replacement and Mortality in Patients with Nonfunctioning Pituitary Adenoma. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2012-2432
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.